PHARMACOKINETICS
Case Narrative
A 53 year old Malay lady was seen in the cardiac clinic for atrial fibrillation. To reduce her risk of developing an embolic stroke, she was prescribed a 75mg oral dose of an anti-coagulant to be taken every 12 hours. The patient is relatively well although clinical lab tests show mild renal impairment.
Relevant Drug Information
The anti-coagulant is a direct thrombin inhibitor with a low bioavailability. It is cleared primarily by renal mechanisms with an average elimination half-life of about 14.3 hours. Large scale clinical studies suggest that the optimal plasma concentrations of the anticoagulant should be between 0.06-0.12 mg/L. Concentrations above 0.12 mg/L are associated with increased risks of life-threatening bleeds.
Would you like to see all the 20 patients in the population?
Multiple Oral Dose (Anticoagulant)
To go back to single patient view, please click "Back to first population" button, then click "Yes" button
